Company Overview and News

 
Orezone Files NI 43-101 Technical Report for its Bomboré Gold Project

2018-08-23 globenewswire
OTTAWA, Aug. 23, 2018 (GLOBE NEWSWIRE) -- Orezone Gold Corporation (TSXV-ORE) announces that it has filed an independent National Instrument (“NI”) 43-101 technical report entitled "Feasibility Study of the Bomboré Gold Project, Burkina Faso” with an effective date of July 9, 2018. The feasibility results were previously announced by the Company in a news release dated July 9, 2018.
ORZCF ORE

 
Orezone Continues to Intersect High-Grade Gold From Its Targeted Infill Drilling Programme at Bomboré

2018-07-31 globenewswire
OTTAWA, July 31, 2018 (GLOBE NEWSWIRE) -- Orezone Gold Corporation (TSXV:ORE) (“Orezone” or the “Company”) is pleased to report ongoing results from its targeted shallow infill Reverse Circulation Drilling (“RC”) and Diamond Core Drilling (“DD”) within the Bomboré mining lease. This programme totalled 196 RC boreholes (12,193 m) and 30 DD boreholes (3,756 m) that were drilled during Q2 2018 in the Maga, P11 and Siga East areas.
ORZCF ORE

9
Gold Mining Bull: Top News For July 2018

2018-07-31 seekingalpha - 2
Detour Gold battles with an activist investor; former Alexandria CEO fails to regain control of company.
WPM NGD LUNMF NEM YRI CPNFD NGDAF LUNCF DRGDF NGD LUN EQXGF ORE NSU ORZCF AUY DGC GG HTXFF

 
Orezone Announces More Drilling Results at Bomboré Project Outside of Existing Mining Permit and Qualified Resources

2018-07-16 globenewswire
OTTAWA, July 16, 2018 (GLOBE NEWSWIRE) -- Orezone Gold Corporation (TSXV:ORE) (“Orezone” or the “Company”) is pleased to report recent Reverse Circulation (“RC”) and Diamond Drilling (“DD”) drilling results from several target areas that lie outside of the main Bomboré deposit mining permit. This programme totalled 55 RC boreholes (2,904 m) and 34 DD boreholes (4,916.5 m) that were drilled during Q1 2018.
ORZCF ORE

1
Orezone Gold: The Updated Feasibility Study Looks Promising, Is A Takeover Now In The Cards?

2018-07-13 seekingalpha
Orezone just released an Updated Feasibility Study highlighting their Bomboré project as possessing: strong economics, modest CapEx, quick payback, simple mine plan, and ample remaining development/exploration upside potential.
ORZCF WFRSF BTG WAF EDVVF EDVMF EVR OCR EDV ORE

 
Orezone Announces Positive Feasibility Study for the Bomboré Gold Project

2018-07-09 globenewswire
OTTAWA, July 09, 2018 (GLOBE NEWSWIRE) -- Orezone Gold Corporation (TSXV:ORE) (“Orezone” or the “Company”) is pleased to announce the summary results of an updated independent Feasibility Study (the “FS”) for its 90%-owned Bomboré Gold Project in Burkina Faso, West Africa. All reported figures are in U.S. dollars and are on a 100% project basis unless otherwise stated.
ORZCF MALRY MALRF MIN ORE

 
Orezone Gold Closes C$44.92 Million Private Placement

2018-04-10 globenewswire
OTTAWA, April 10, 2018 (GLOBE NEWSWIRE) -- Orezone Gold Corporation (TSX-V:ORE) (“Orezone” or the “Company”) is pleased to announce that it has closed its non-brokered private placement (the “Offering”) previously-announced on March 26, 2018. The Company has sold 56,150,000 common shares of the Company (“Common Shares”) at a price of C$0.80 per share for gross proceeds of C$44,920,000. The Common Shares issued pursuant to the Offering will be subject to a four month hold period expiring on August 10, 2018.
ORZCF ORE

 
BRIEF-Resource Capital Fund VII announces acquisition Of 19.99 pct of Orezone Gold Corp shares

2018-04-10 reuters
* RESOURCE CAPITAL FUND VII L.P. ANNOUNCES ACQUISITION OF 19.99% OF SHARES OF OREZONE GOLD CORPORATION
ORZCF ORE

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to TSXV:ORE / Orezone Gold Corporation on message board site Silicon Investor.

Qualcomm Moderated Thread - please read rules before posting Qualcomm Moderated Thread - please read rules before posting Qualcomm Moderated Thread - please read rules before posting Anything graphite based, CCB, Zen and hopefully much more. Anything graphite based, CCB, Zen and hopefully much more. Anything graphite based, CCB, Zen and hopefully much more.
Foreign Policy Discussion Thread Foreign Policy Discussion Thread Foreign Policy Discussion Thread Neptune Technologies u0026 Bioressources Inc. - NTB.V Neptune Technologies u0026 Bioressources Inc. - NTB.V Neptune Technologies u0026 Bioressources Inc. - NTB.V
Africa and its Issues- Why Have We Ignored Africa? Africa and its Issues- Why Have We Ignored Africa? Africa and its Issues- Why Have We Ignored Africa? Test Your HTML Here Before You Post It! Test Your HTML Here Before You Post It! Test Your HTML Here Before You Post It!
Core Gold Inc Core Gold Inc Core Gold Inc American Presidential Politics and foreign affairs American Presidential Politics and foreign affairs American Presidential Politics and foreign affairs
Foreign Affairs Discussion Group Foreign Affairs Discussion Group Foreign Affairs Discussion Group Corel Corp. Corel Corp. Corel Corp.